Attention Deficit Disorder: To Treat or Not to Treat?(Brief Article)Trifiletti, Rosario
The invention relates to the utilization of phosphatidylserine (PS), lysophosphatidylserine and/or a physiologically acceptable salt thereof in the treatment of attention deficit syndrome (ADHS) in small daily doses over an extended period and in high doses over a short period and in combination wi...
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with ... Intent-to-treat analyses of the study revealed that medication management, alone or combined with intensive behavioral treatment, was superior to ...
(HealthDay)—Marketing has been approved for the first medical device to treat attention-deficit/hyperactivity disorder (ADHD), the U.S. Food and Drug Administration announced Friday.
科学理解合理诊治注意缺陷多动障碍郑毅.专论.注意缺陷多动障碍( attem i ondefi ci thyperacdvi ty di sofder,ADH D) 亦被称为儿童多动症、多动障碍或多动综合征。尽管人们对AD H D 的认识已逾百年,但AD H D 是病还是毛病?是心理的问题还是生理的问题?是儿童特有的问题还是儿童青少年和成人共同的问题?
WASHINGTON, April 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) approved this week the first medical device to treat attention deficit hyperactivity disorder (ADHD) for children. The device called the Monarch external Trigeminal Nerve Stimulation (eTNS) System is the first non-dru...
There is "good evidence" that drugs to treat attention deficit hyperactivity disorder (ADHD) might also successfully treat key aspects of Alzheimer's disease, finds a pooled data analysis of the available research, published online in the Journal of Neur
Attention Deficit Disorder As a young boy in elementary school I was supposedly diagnosed with Attention deficit disorder. To this day both my father and I never believed that I really had ADD. Attention deficit disorder (ADD) is the subject of two widely challenged debates in medicinal practice...
The recently most largely prescribed drug to treat Attention Deficit and Hyperactivity Disorder (ADHD) is methylphenidate. Methylphenidate is a drug that works by stimulating the "Alfa" and "Beta" adrenoceptors, in direct and indirect ways, through the liberation of Dopamine and Noradrenalin, acting...
“The Metabotropic Glutamate Receptor Subtype 7 rw 3792452 Polymorphism is Associated with the Response to Methylphenidate in Children with Attention-Deficit/Hyperactivity Disorder” J. Child Adolesc. Phychopharmacoloty 24(4): 223-227 (2014). The Research Unit on Pediatric Psychopharmacology Anxiety ...